Estimated Opioid-Related Costs $14 Billion for Symptomatic Knee OA
THURSDAY, Feb. 25, 2021 -- The total lifetime opioid-related costs generated by symptomatic knee osteoarthritis (SKOA) in the United States are $14.0 billion, about half of which can be attributed to lost productivity, diversion, and criminal justice costs, according to a study published online Feb. 24 in Arthritis Care & Research.
Jamie L. Huizinga, from Brigham and Women's Hospital in Boston, and colleagues characterized the societal economic burden of opioid use among patients with SKOA. The Osteoarthritis Policy Model was used to estimate the opioid-related lifetime and annual costs generated by the U.S. SKOA population. The annual costs of strong and weak opioid regimens were estimated, and annual lost productivity and criminal justice costs of opioid use disorder, obtained from published literature, were included.
The researchers found the total lifetime opioid-related cost generated by the U.S. SKOA population was estimated at $14.0 billion, assuming a prevalence of 5.1 percent for chronic strong opioid use. Of the total costs, 53 percent were direct medical costs, 15 percent were lost productivity costs, 30 percent were diversion of opioid prescription costs, and 2 percent were criminal justice costs.
"These data offer new evidence of the magnitude of the societal burden generated by opioid use and misuse and could be used to educate health care providers and health policy decision makers on the best alternatives to opiate use," a coauthor said in a statement.
The study was partially funded by a grant from Pfizer.
© 2021 HealthDay. All rights reserved.
Posted: February 2021
Read this next
WEDNESDAY, April 7, 2021 -- Among patients with normal renal function at baseline who are treated with a high-dose antibiotic-loaded bone cement (ALBC) spacer and systemic...
MONDAY, April 5, 2021 -- Annual medical costs associated with substance use disorder (SUD) in U.S. emergency departments and inpatient settings exceeded $13 billion in 2017,...
FRIDAY, April 2, 2021 -- There have been recent increases in overdose deaths involving both cocaine and opioids and involving both psychostimulants and opioids, according to an...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.